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We have  previously  shown  that  the  growth  hormone 
(GH) receptor-binding  protein is associated  with  the  nu- 
cleus. We show  here  both  by  electron  microscopy  and 
nuclear isolation that GH is subject to rapid nuclear 
translocation.  The  intracellular  fate  of  intravenously in- 
jected  ‘261-bovine  growth  hormone  (bGH)  was  examined 
in  the  rat  hepatocyte  by  electron  microscopic  autora- 
diography.  The  hormone  appeared  rapidly  at  the  plasma 
membrane,  then  sequentially  in  lysosomal  and  multive- 
sicular  bodies andor the  nuclear  membrane  before  final 
translocation  to  the  nuclear  matrix.  Maximal  transloca- 
tion  to  the  nuclear  matrix  occurred  within 30 min of 
injection. Nuclear translocation of lZ6I-hGH was also 
studied by isolation of nuclei from cells  stably  trans- 
fected  with cDNAs  encoding  the GH receptor,  GH-bind- 
ing  protein,  and  a  membrane  bound  but  cytoplasmic  do- 
main-deficient receptor. Specific internalization and 
nuclear  translocation of hormone  only  occurred  in cells 
transfected  with  the  full-length  receptor.  The  transloca- 
tion  was  rapid  and  became  saturated  within 1 h  after 
addition  of  hormone  to  the  culture  media.  SDS-polyac- 
rylamide  gel  electrophoresis  of  isolated  nuclei  showed 
that GH is  transported  to  the  nucleus as the  intact  mol- 
ecule. Pretreatment  of cells  with  lysosomotropic  agents 
(chloroquine,  ammonium  chloride,  and  bacitracin)  de- 
creased hormone degradation and increased nuclear 
translocation  of GH. The  nuclear  translocation  of GH 
was achieved independent of the cytoskeletal system 
(microtubular,  microfilament,  and  intermediate fila- 
ment  networks).  Thus, GH is subject  to  rapid  receptor- 
dependent  nuclear  translocation  via  the  endosomal 
pathway. 
Growth  hormone (GH)’ is the major  regulator of postnatal 
body growth  (1) and is  thought  to  initiate  its biological actions 
by  interaction  with a specific plasma  membrane  bound  receptor 
(2-6). A GH-binding  protein  (BP)  derived  by  alternate  splicing 
of the GH  receptor  gene  exists in the rat (7) and  mouse (8). We 
(9-11) and  others (12) have  recently  shown that the  growth 
hormone  receptor-BP is associated  with the nucleus. We pro- 
posed that the nuclear  association of the GH  receptor-BP  may 
be  one  mechanism  by  which  specific  GH-dependent  gene tran- 
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scription is achieved. It has been  reported that after  binding  to 
a cell  surface  receptor  GH is internalized and is selected  for 
lysosomal  degradation (13-16) or  exocytosis (17), presumably 
via  the Golgi apparatus (18). However, there is evidence that at 
least some  polypeptide ligands undergo  nuclear  translocation 
subsequent  to  internalization (for review, see Ref. 19).  Such is 
the case  for  the  homologous  hormone  prolactin  (20,211 as well 
as for insulin (22, 231, nerve  growth  factor  (24, 251, EGF (26- 
281, thyrotropin releasing hormone (29, 30), somatostatin-28 
(311, Neuropeptide Y (321, platelet-derived  growth  factor (28), 
atrial natriuretic  peptide  (33),  gonadotropin  releasing  hormone 
(341, FGF (351, interleukin-la  (36),  and p and 6 interferons  (37). 
However, an early  ultrastructural  study  failed  to  demonstrate 
that GH is subject  to  nuclear  translocation (13). In  contrast, 
iodinated  bGH  administered  in vivo has been  shown  to  associ- 
ate with a crude  nuclear  fraction  derived  from rat liver  and 
kidney (38) and [3HlhGH incubated with human liver slices 
was  found  to  be  preferentially  incorporated  into a nuclear  frac- 
tion (39). 
We have  therefore  been  prompted  to  re-examine the intra- 
cellular  movement of GH. To achieve  this  we  used  quantitive 
electron microscopic autoradiography and nuclear isolation 
from cDNA-transfected cells expressing the GH receptor or 
GHBP (5). We show  rapid  receptor but not  BP-dependent nu- 
clear  translocation of growth  hormone via the endocytotic  ly- 
sosomal  route. 
MATERIALS AND METHODS 
Iodination of Hormones-Recombinant hGH was a generous gift 
from Kabi-Pharmacia (Stockholm, Sweden). Recombinant bGH was a 
gift  from  American  Cyanamid (St. Louis,  MO).  hGH  was iodinated by 
the IODO-GEN method (40) and fractionated on a Sepharose G-25 
column. bGH was iodinated by the lactoperoxidase method (41) and 
separated on a Sepharose G-100 column.  Specific activity of hGH was 
80-153  pCi/pg protein. Specific activity of bGH was 120  pCi/pg protein. 
Animal Deatment, Tissue Fixation, and Autoradiography-Ten- 
week-old male GH-deficient  Lewis  dwarf rats (42) were  housed at room 
temperature on a 12-h light-dark cycle. Animals were  fed a diet of rat 
pellets and water ad libitum. Lewis dwarf rats were chosen as the 
paucity of endogenous GH  would minimize  competition with the admin- 
istered radiolabeled hormone. Animals were anesthetized with ether 
and injected intracardially with 0.5  ml of PBS containing 4.4 x lo7 cpm 
of Y-bGH. To test specificity of lZ5I-bGH uptake, another group of 
animals were  concomitantly injected with 100-fold  excess of unlabeled 
bGH. Rats were killed by cervical  dislocation at 2,5,  15,30,60, and 120 
min after injection. The upper lobe of the liver was excised, l-mm3 
pieces  were  removed and immersion fured in 2.5% glutaraldehyde in  0.1 
M phosphate buffer  for 1 h. After  furation the tissues were  washed in 
PBS,  postfixed in 1% OsO, for 1 h, dehydrated in ethanol, and embed- 
ded in  Spurr’s resin. Serum from the animals was also concomitantly 
removed and y counted  to determine the rate of removal of hormone 
from the circulation. For light microscopic autoradiography semi-thin 
weeks. Slides were  developed in Dl9 (Kodak) for 2 min and stained with 
sections were immersed in NTB, nuclear emulsion and exposed for 2-i 
toluidine blue. 
For electron microscopic autoradiography ultrathin sections were 
coated with Ilford L4 emulsion using a loop to obtain a monolayer of 
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densely packed silver bromide crystals (43). Ultrathin sections were 
developed in  Dl9 developer (2  min)  and  stained  as previously  described 
(29, 43, 44). 
Quantitative  Analysis  ofElectron Microscopic Autoradiography-The 
analysis of silver  grain  distribution  was  performed at the  ultrastruc- 
tural level. To achieve  random  selection  in a given grid  square  every cell 
sectioned through the nucleus was photographed. The percentage of 
grains  related  to  the  organelles  was  evaluated on micrographs  (magni- 
fication x 20,000) by the probability circle method.  The  circular area of 
460  nm  in  diameter  having  the  silver  grain at its  center  encloses  the 
radioactive  source  with a probability of 95% (45).  If only one  organelle 
was localized within  the circle, the  grain  was  classified  as exclusive. 
According to  the method of Nadler  (45)  the  shared  grains  were  assigned 
on  the  basis of probability to only  one  structure.  The  corrected  number 
of grains for each  organelle  was  the  sum of the exclusive and  adjusted 
shared  grains  and  was  expressed  as  a  percentage of the  total  number of 
corrected  grains.  Since the  error  in  random  counting  is  proportional  to 
the  square  root of the  number of counts,  up  to 500 silver  grains  were 
counted for each  time  point.  After  obtaining  the  corrected  grain  counts 
the  relative  concentration of label  in  each  organelle  was  calculated by 
dividing the  percentage of silver  grain by the  percentage of area occu- 
pied by the organelles (Table I). A  grain  density  greater  than  one  is 
considered  to  represent specific labeling (46). Determination of back- 
ground  counts  was  performed  on  animals  simultaneously  injected  with 
100-fold excess  unlabeled bGH. This  background  count  was  less than 
10%  of the  grain  frequency  determined over labeled cells. Background 
was  also  estimated over an  area of Spurr  alone  and  was  found  to  be  less 
than 3%. 
Cellular  Dansfection of GH Receptor and GHBP cDNA-Rat GH 
receptor and GHBP cDNAs were cloned into an expression plasmid 
containing an  SV40 enhancer and a metallothionin promoter. The 
cDNAs were  transfected  into CHO-K1 cells with lipofectin together  with 
the pIPB-1  plasmid  which  contains a neomycin-resistance  gene  fused  to 
the  thymidine  kinase promoter. Stable  integrants  were  selected  using 
1000 pg/ml G418. The  complete  rat GH receptor cDNA (3) coding for 
amino  acids 1-638 was  expressed  in  CH04-638  or CHOA-638 cells (5). 
A  stop codon was  created a t  amino acid 295 by in vitro  mutagenesis of 
GH  receptor cDNA to create a membrane  bound  but  cytoplasmic do- 
main-deficient receptor. This cDNA was  expressed in CHO-294 cells (5). 
The rat  GHBP cDNA consisted of the  extracellular  portion of the recep- 
tor cDNA (corresponding to amino acids (1-262) ligated to a cDNA 
sequence  corresponding  to the carboxyl-terminal  17  amino  acids of the 
GHBP (7)). GHBP was expressed in CHO-BP2 cells (5). BRL cells 
(ATCC) were  transfected  with  the complete rat GH receptor cDNA in- 
serted  in  an expression vector containing  the  human  cytomegalovirus 
enhancer  and  promoter  (pcDNAl)  (6). 
Hormone  Internalization,  Degradation, and Nuclear Uptake in 
Dansfected Cells-For hormone  internalization  and  degradation  assays 
CHO cells were grown to confluence in 6-well plates  in Ham's F-12 
medium  supplemented  with 10% fetal calf serum, 50 unitdm1 penicillin, 
and 50 pg/ml streptomycin.  For  estimation of hormone  nuclear  uptake, 
cells were  similarly  grown to confluence in 100-mm diameter  dishes. 
When  hormone  internalization  was  compared  to  hormone  nuclear up- 
take  both  assays  were  performed  in 100-mm diameter  dishes. BRL cells 
were grown in Dulbecco's modified Eagle's medium  supplemented  with 
10% fetal  calf  serum,  50  unitdml penicillin, and  50 pg/ml streptomycin. 
Confluent cells were  incubated  in  serum  free  medium for 12  h before 
addition of 1251-hGH (approximately 150,000 cpdwell).  For  BP2  cells 
the media  was  changed  immediately before hormone  addition to pre- 
vent  interference from soluble  GHBP in  the media. Nonspecific or non- 
receptor-mediated  uptake  was  estimated by the addition of 10 pg/ml 
unlabeled  hGH  to the media.  For  estimation of hormone  internalization 
the media was removed, the cells were washed once with PBS, cell 
surface  bound  hormone  was removed by washing  the cells with 5 ml of 
PBS-HCl  (pH 3) for 1 min  (47),  the cells were  washed  twice  with 5 ml of 
PBS,  solubilized  with 0.1 M NaOH, 1% SDS,  scraped,  and  transferred to
tubes for y spectrometry. Cell surface  receptor  was  estimated by incu- 
bation of cells at 4 "C for 4  h  with lZ5I-hGH and nonspecific binding 
determined by the  addition of 10 pg/ml unlabeled hGH. Degraded GH is 
released  into  the  media  as  iodotyrosine  (16).  Hormone  degradation  was 
estimated by trichloroacetic acid precipitation  (10%) of media and  quan- 
titation of radioactivity in  the  supernatant. Rapid  isolation of nuclei 
was  performed  similarly as  previously described  (48).  The  nuclei iso- 
lated  were  free from membrane  and  cellular  organelle  contamination 
(Fig.  4, a and 6 ) .  Cells  were  washed 3 times  in  PBS before removal  with 
a  rubber policeman. Cells  were  centrifuged at 800 x g, the  supernatant 
removed, resuspended  in a nuclear  isolation  buffer  containing  10 mM 
Ms-HCl  (pH 7.4),  10 mM MgCI,, 10 mM benzamidine  hydrochloride, 3 
mM aminoacetonitrile hydrochloride, and 0.5% Nonidet P-40. Extracts 
were vortexed for 10 s, placed on ice for 5 min,  centrifuged at 400 x g,  
the  supernatant removed and  the process repeated twice more. Pellets 
were  counted  on an  LKB y spectrometer. 
Electron Microscopy of Isolated Nuclei-To verify the  purity of nuclei 
isolated by our protocol we subjected the  nuclear  fraction  to  electron 
microscopic analysis. Nuclei were  resuspended  and fixed in 0.1 M caco- 
dylate  buffer  (pH 7.2) containing 1% glutaraldehyde, 3% paraformalde- 
hyde,  and 5% sucrose for 4  h a t  4 "C. The nuclei were  then pelleted by 
centrifugation  and  stored  in 0.1 M cacodylate buffer a t  4 "C. The  pellets 
were postfixed with  1% osmonium tetroxide  in  veronal  acetate buffer 
(pH 7) for 1 h,  dehydrated  in a graded  ethanol  series,  and embedded in 
Araldite epoxy resin. Sections were stained with uranyl acetate and 
lead  citrate. 
SDS-Polyacrylamide Gel Electrophoresis of Nuclear Danslocated 
'2sI-hGH-To determine the molecular mass of nuclear translocated 
Iz5I-hGH we subjected  isolated nuclei as  prepared above to SDS-PAGE. 
Nuclei isolated from CH04-638 and CHOA-638 cells and iodinated 
hormone were boiled in SDS sample buffer with dithiothreitol and 
electrophoresed on a 9% acrylamide gel. Gels  were  dried  and  autora- 
diographed  with Kodak AR-5 film in  an x-ray cassette  with  intensifying 
screens a t  -85  "C. 
Drug Deatments-Colchicine, vinblastine,  vincristine, demecolcine, 
acrylamide, cytochalasin B, cytochalasin D, chloroquine, ammonium 
chloride, and  bacitracin  were  obtained from Sigma.  Cytochalasin  B  and 
D were dissolved in ethanol. Cells were cultured and processed as 
de cribed above and exposed to  all  drugs  (except demecolcine) for 1 h 
prior to the addition of "'I-hGH (approximately 150,000 cpm). Cells 
were exposed to demecolcine for 2  h  (49) before nuclear  uptake  was 
commenced. Colchicine, vinblastine, vincristine, cytochalasin D, and 
I 
FIG. 1. Specificity of cellular uptake of '"I-bGH in uiuo. Light 
micrographs are derived from semithin  sections of rat liver  50  min  after 
injection of '*'I-bGH. Semithin  sections were obtained  and  autoradio- 
graphed as  described under  "Materials  and Methods." Sections were 
exposed for 30 days. a, liver from rat injected with '251-bGH; b, liver 
from rat injected concommitantly  with 12'I-bGH and 100-fold excess of 
unlabeled bGH. 
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phalloidin were each used at 10 PM, demecolcine at 5 m, cytochalasin B 
at 20 J~M, acrylamide at 5 mM, chloroquine at 10 m, ammonium  chlo- 
ride at 50 mM, and bacitracin at 5 mg/ml. The cells  were in  the continued 
presence of the drugs for the duration of the hormone processing 
experiments. 
Immunofluorescence for Cytoskeletal  Integrity-Cells  were  grown on 
coverslips in 6-well plates and treated exactly as described above in 
terms of serum deprivation and  drug  treatment. Cells  were  fixed  for 10 
min in 4% paraformaldehyde, PBS (pH 7.4) at room temperature  and 
washed with PBS (pH 7.4). The following reagents directed against 
cytoskeletal components were used: (a) a mouse anti-rat brain P-tubu- 
lin monoclonal antibody for demonstration of the microtubular network 
(Sigma; dilution 150); (b) mouse anti-pig eye lens vimentin for  demon- 
stration of the intermediate filament network (Sigma; dilution 150); 
and (c) rhodamine phalloidin for demonstration of the microfilament 
network (Sigma; 5 pg/ml). Cells were permeabilized with PBS, 0.1% 
Triton X-100 for 1 min and  further washed with PBS, 1% bovine serum 
albumin. Nonspecific IgG binding was prevented by incubation with 
10% normal sheep serum in PBS, 1% bovine serum albumin for 1 h. 
Cells  were incubated for 12 h at 4 "C with the appropriate dilution of 
primary antibody,  washed 4 times with PBS, and once with PBS, 1% 
bovine serum albumin, incubated 60 min with fluorescein isothiocya- 
nate-conjugated second antibody (Amersham; sheep anti-mouse IgG 
dilution 150) washed 3 times with PBS, and mounted in glycerol. For 
demonstration of the microfilament network, permeabilized  cells  were 
incubated with rhodamine phalloidin for 12 h at 4 "C and washed 3 
times in PBS. 
Statistics-All data are expressed as mean S.E. Data were ana- 
lyzed using the two-tailed t test or ANOVA. Results were  considered 
significant at the 5% level. 
RESULTS 
Cellular Uptake of Iz5I-bGH into Rat Hepatocytes-To study 
the in vivo cellular uptake of GH we injected "'I-bGH intrave- 
nously into  male Lewis dwarf rats and examined the hepato- 
cytic subcellular localization of the hormone by electron micro- 
TABLE I 
Relative  percentage of area occupied by each cellular compartment 
in rat hepatocyte 
Cellular  compartment  Relativ   surf ce  area 
% 
Plasma membrane and cytoplasm near 6.1 
Golgi apparatus 0.3 
Lysosome 0.8 
Cytoplasmic matrix and rough 37.2 
Glycogen area 26.4 
Mitochondrion 19.5 
Lipid droplets 0.2 
Nuclear membrane 1.5 
Nuclear matrix 7.2 
This cytoplasm area corresponds to an  annulus equal in width to 
plasma membrane" 
endoplasmic reticulum 
the radius of the probability circle. 
scopic autoradiography at 2, 5 ,  15, 30, 60, and 120  min after 
injection. Somatogenic specificity was achieved by use of bGH 
as opposed to  hGH which is both somatogenic and lactogenic 
(50). We also  concommitantly followed the loss of GH from the 
circulation by measurement of serum radioactivity. A sharp 
decline was  first observed between  2 and 5 min  after injection 
followed by a slower loss to 120  min, presumably due  to com- 
plex formation with  the  plasma GH-binding  protein (51). Au- 
toradiographic specificity was  demonstrated by concommitant 
injection of the  animal  with 100-fold excess of unlabeled bGH. 
The specificity is demonstrated  in Fig. 1, a and b, where the 
density of signal  is significantly  reduced by excess unlabeled 
hormone. Grain  density (percentage of total  graindpercentage 
of total cell area) over the different  cellular compartments was 
calculated. The  area occupied by each  cellular compartment  is 
given in Table I. The rough endoplasmic reticulum  with  the 
cytoplasmic matrix occupied the  greatest  area (37.2%),  followed 
by the glycogen area (26.4%) and the mitochondrial area 
(19.5%). None of the other compartments constituted more 
than 8% of the total cellular area. The percentage of silver 
grains counted over various cell compartments  are  summarized 
in Table 11. To evaluate  the specific labeling pattern  the  grain 
density was determined for each compartment. Quantitive 
analysis revealed that seven compartments (plasma mem- 
brane, cytoplasmic matrix including the rough ER, Golgi appa- 
ratus, lysosomes, mitochondria, nuclear membrane, and nu- 
clear  matrix) displayed specific labeling (grain  density > l; Ref. 
46). Glycogen and lipid  droplet compartments were not specifi- 
cally labeled (Table 11). The different cellular compartments 
displayed  differential kinetic association with lZ5I-bGH. Silver 
grains were initially localized to  the  plasma  membrane (Figs. 
2a  and 3 A )  (within 2 min  after injection) and declined gradu- 
ally until 60 min  in  this  compartment  with a slight recovery at 
120 min. The lysosomal compartment (Figs. 2c and 3B) dis- 
played biphasic  labeling with  maxima at 5 and 60 min  after 
injection. Specific labeling of the lysosomal compartment was 
not observed at 2 and 15 min. Specific labeling of the Golgi 
apparatus  was also observed (Fig. 2b and 30). Labeling of the 
mitochondrial compartment  was consistently  high (around 25% 
of total silver grains) at  all time points  examined  (Figs. 2b and 
3C). The labeling of the  nuclear  membrane (Figs. 2d and 3e) 
was specific at 5 min,  attained a maximum value a t  30 min, 
then declined and remained constant 60 and 120 min after 
injection. Silver grains  were also  associated with  the  nuclear 
pore. Specific labeling of the  nuclear  matrix (Figs. 2d and 3f) 
was  first observed 30  min after injection.  Within the nucleus, 
silver grains  were most frequently detected at  the euchroma- 
TABLE I1 
Relative percentage of total grains counted and grains densities for cellular organelles of rat hepatocytes 2-120 rnin 
after injection of Iz5Z-bGH 
2 min 
Cellular  compartment 
5 min 15 min 30 min  60  min 120 min 
% GD" % GD % GD % GD % GD % GD 
Plasma membrane and cytoplasm 
Golgi apparatus 
Lysosome 
Cytoplasmic matrixand endoplasmic 
reticulum 
Glycogen area 
Mitochondria 
Lipid droplets 
Nuclear membrane 
Nuclear matrix 
near plasma membrane 
24.9 4.1 22.5 3.7 
0.0 0.0 0.2 0.7 
0.0 0.0 2.6 3.3 
16.8 0.6 35.1 1.3 
23.8 0.9 11.1 0.4 
28.2 1.4 20.8 1.1 
0.0 0.0 0.0 0.0 
0.7 0.5 2.6 1.7 
5.6 0.8 5.7 0.8 
16.1 2.6 12.6 2.1 
0.4 1.3 0.7 2.3 
19.3 0.7 26.6 1.0 
0.8  1.0  1.4 1.8 
24.5 0.9 18.9 0.7 
30.3 1.6 21.3 1.1 
0.0 0.0 0.0 0.0 
2.4 1.6 4.9 3.3 
6.2 0.9 13.6 1.9 
11.7 1.9 
1.1 3.7 
21.4 0.8 
3.0 3.8 
18.8 0.7 
32.7 1.7 
0.2 1.0 
2.2 1.5 
8.9 1.2 
16.6 2.7 
0.2  0.7 
25.2 0.9 
1.4 1.8 
18.6 0.7 
25.7 1.3 
0.0 0.0 
2.3  1.5 
10.0 1.4 
Number of silvergrains counted 446 423 466 486 462 429 
GD, grain density: percentage of silver grain  in one particular compartment/percentage of this cellular compartment area (see Table I). 
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under  "Materials  and Methods." a ,  silver  grains localized over the  plasma  membranc 2 min after injection of 12"I-bGH. b, silver  grains localized over 
FIG. 2. Electron microscopic au toradiograms of hepatocytic  internalization of "JI-bGH. Autoradiograms  were  prepared  as  described 
lysosomal bodies 5 min  after  injection of ""I-bGH. c, silver  grains localized over the Golgi apparatus,  cytoplasmic  matrix,  and  mitochondria 15 min 
after  injection of  '"I-bGH. d,  silver  grains  observed over nuclear  membrane  particularly  nuclear pore (arrows) and  nuclear  matrix. e,  silver  grains 
localized over the  nuclear  membrane  and  nuclear  matrix 60 min  after  injection of  12"I-bGH. Magnification bar  equals 0.5 pm. 
tin-heterochromatin  junction. rity of the isolated nuclei is  demonstrated in Fig. 4, a and b). We 
Internalization  and  Nuclear  Uptake of IZ5Z-hGH in GH Re- therefore  first examined the  time course of internalization  and 
ceptor- and  GHBP cDNA-transfected Cells-GH receptor-trans- compared this  to  nuclear  uptake. Both internalization  and  nu- 
fected CH04-638 cells were previously shown to internalize clear  uptake proceeded rapidly  but  the  rate of accumulation of 
hormone to a considerably greater  extent  than  the  untrans- 12"I-hGH in  the nucleus was slower than  the  rate of internal- 
fected parental cell line (52). We wished to determine if the ization  (Fig. 5A).  Also, the  times a t  which saturation of inter- 
receptor could also mediate hormone nuclear  uptake  (the  pu- nalization and nuclear uptake was achieved was different. 
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A 5l PLASMA MEMBRANE LYSOSOMES  AND  MULTNESICULAR  BODIES 
R 
3 c  I\ 
21 MITOCHONDRIA D 
E 41 NUCLEAR  MEMBF’ANE F 
41 
* r  
1 
P 
NUCLEAR  MATRIX 
1 
0 2 5 1 5  30 60 1 2 0  
TIME  AFTER  INJECTION  (MINUTES) 
FIG. 3. Kinetic  analysis of the  intracellular  fate of internalized lasI-bGH in the  rat  hepatocyte  determined by electron  microscopic 
Methods.” Grain density values above  one are considered significant. ( A )  plasma membrane; ( B )  1ysosomaYmultivesicular  bodies; ( C )  mitochon- 
autoradiography. Grain density (percentage of total graindpercentage of total cell area) was determined as described under “Materials and 
dria; ( D )  Golgi apparatus; ( E )  nuclear membrane, and ( F )  nuclear matrix. 
Maximum internalization of hormone was achieved at 2 h, 
whereas hormone accumulation in the nucleus was saturated 
within 1 h (Fig. 5 A ) .  Maximum nuclear uptake of hormone 
represented approximately 20%  of total internalized hormone. 
With the continued presence of lZ5I-hGH there was a slight 
decrease in both total hormone internalized and hormone  ac- 
cumulation in  the nucleus with time (to 8 h). It has previously 
been reported that internalization of hormone is  temperature 
dependent and no internalization occurs at 4 “C  (Ref.  52 and 
references therein). Similarly, when  cells  were incubated with 
lZ5I-hGH at 4 “C no specific nuclear uptake of hormone was 
observed despite ample cell surface receptor binding. Thus hor- 
mone uptake to the nucleus is a specific receptor-mediated 
phenomenom. We verified this observation by use of 2 more  cell 
lines stably transfected with cDNA for the full-length receptor. 
Results for  CHOA-638  cells were similar but  greater in mag- 
nitude to that obtained for CH04-638 cells under the same 
conditions (Fig. 5, B and C). These observations were not due to 
membrane contamination as no nuclear uptake (when normal- 
ized to  total cellular binding) was observed in cells transfected 
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FIG. 4. Electron  micrograph  of  nuclei purified from CH04-638 
cells as described under “Materials  and  Methods”. a, low magni- 
fication  photomicrograph of the  nuclear  preparation.  Many  nuclei  are 
morphologically distorted and show spillage of nuclear content. No 
other  cellular  organelles  were  present  in  the  preparation. b, high  mag- 
nification  photomicrograph of the  nuclear  preparation to demonstrate 
lack of membranous  contamination. 
with a membrane bound but cytoplasmic domain-deficient re- 
ceptor (CHO-294: Ref. 5) (data  not shown). This cell line  has 
previously been demonstrated  to bind GH without  internaliza- 
tion (52). Since the electron microscopic observations  were per- 
formed in  rat liver we also examined a rat liver cell line  trans- 
fected with  the full-length  receptor (BRL4-638). Again similar 
results were  obtained  with  approximately 20% of internalized 
hormone  associated with  the nucleus at 1 h (data not shown). 
We also wished to  determine if the GHBP could mediate  either 
internalization or nuclear  uptake of the hormone. Thus experi- 
ments were performed with CHO cells transfected with the 
GHBP containing the hydrophilic carboxyl terminus (BP2). 
Neither  internalization nor nuclear  uptake  (quantity or rate) 
was  altered  in comparison to  the  parental cell line (Fig. 5, B 
and C). Thus  the  BP  in isolation is not involved in  these proc- 
esses. No significant differences in trichloroacetic acid soluble 
radioactivity in  the media was observed between the different 
CHO cell lines. 
Molecular Mass of Nuclear  Danslocated hGH-It has previ- 
ously been demonstrated  that GH is susceptible to  partial pro- 
teolysis by endosomal fractions in vitro (53). We wished to 
determine  whether  intact GH or a GH fragment  was  translo- 
cated to  the nucleus. We therefore  isolated nuclei from CH04- 
638 and CHOA-638 cells incubated in  the presence of  ‘251-hGH 
for 90 min  as described above, solubilized, and subjected the 
nuclei to SDS-PAGE. As is observed in Fig. 6, ‘251-hGH  of the 
same molecular mass (22,000) as  the added hormone was also 
extractable from the  nuclear fraction. Radioactive degradation 
products running at the gel front were observed in all samples 
analyzed including the added hormone. Thus hGH is  trans- 
ported to  the nucleus as  the  intact molecule. 
Effect of Lysosomotropic Agents on Hormone Nuclear 
Uptake-One of the known target organelles for GH within the 
cell is  the lysosome, where  it undergoes  energy-dependent deg- 
radation (13). When ‘251-GH is used the degraded hormone is 
released into  the media as trichloroacetic acid soluble iodoty- 
rosine (16). Lysosomotropic agents (chloroquine and ammo- 
nium chloride) have previously been demonstrated  to decrease 
the degradation of 1251-GH (14). Since the majority of early 
internalized hormone is directed either  to  the lysosomal com- 
partment or to  the nucleus we wished to  determine  the ffect of 
prevention of degradative processing on nuclear uptake of GH. 
Both 10 mM chloroquine and 50 mM ammonium chloride were 
effective in decreasing hormone degradation in both receptor- 
transfected cell lines  (CH04  and CHOA) (Fig. 7A). This de- 
crease in degradation led to an apparent increase in the 
amount of internalized hormone as described previously (Refs. 
14 and 17, and references therein). Chloroquine produced a 
small decrease in cell surface  receptor expression. Nuclear up- 
take of hormone was significantly increased by treatment of the 
cells with these two lysosomotropic agents (Fig. 7A). Thus di- 
version of the hormone from degradative processing allows fur- 
ther  nuclear  uptake of hormone. In  support of this we also 
found that bacitracin (a known inhibitor of insulin  degrading 
activity  (54))  decreased  degradative processing of GH and con- 
commitantly resulted  in increased nuclear uptake (Fig. 7B). 
This effect was observed in both receptor-transfected CHO cell 
clones. 
Effect of Cytoskeletal Disrupting Agents on Nuclear Uptake of 
GH-To examine whether  the nuclear uptake of GH was me- 
diated by the cytoskeletal  system we selectively disrupted the 
three major components with specific pharmacologic agents 
(49,5549).  Thus  the microtubular  system was disrupted  with 
colchicine, vinblastine, and vincristine, the microfilament sys- 
tem with cytochalasin B, cytochalsin D, and phalloidin and  the 
intermediate  filament system  with demecolcine and acrylam- 
ide. These  drugs  have well documented effects on the cytoskel- 
eta1 network (55, 59). We also  concurrently  measured cell sur- 
face receptor and hormone internalization  and degradation for 
control purposes. None of the  three microtubular disrupting 
drugs affected the level of cell surface receptor, hormone deg- 
radation, or nuclear  uptake,  although a significant  increase in 
hormone internalization  was observed with colchicine, vinblas- 
tine,  and vincristine (Fig. 8 A ) .  That  these  drugs were pharma- 
cologically active at the utilized  concentration is evidenced by 
morphological changes (cell rounding), the disappearance of 
the microtubular  network  with colchicine, and  the disappear- 
ance of the microtubule network and formation of tubulin 
paracrystals  with vincristine and vinblastine (data not shown). 
Even higher concentrations  (40 p ~ )  of the microtubular dis- 
rupting  drugs were without effect on the nuclear uptake of GH. 
Drugs affecting the microfilament system (cytochalasin B, cy- 
tochalasin D, and phalloidin) did not significantly affect any of 
the indices of cellular  hormonal processing (Fig. 8C) despite 
gross morphological changes  including bulging of the nucleus 
and complete disruption of the microfilament system (data not 
shown). Again higher concentrations (100 p ~ )  of the microfila- 
ment  disrupting  drugs were without effect on nuclear  uptake of 
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FIG. 5. Internalization and nuclear uptake of '%hGH in the 
CHO parental cell line and CHO cells stably transfected with 
the GH receptor and GHBP cDNA. Estimation of internalized hor- 
mone and  hormone  nuclear  uptake  was  performed as  described  under 
"Materials  and Methods." Each  point is the  mean = S.E. of triplicate 
estimations. The results shown are representative of three experi- 
ments. A, time  course of  '251-hGH internalization  and  nuclear  uptake  in 
receptor-transfected cells (CH04-638). Cells were prepared as de- 
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FIG. 6. SDS-PAGE of nuclear translocated '"1-hGH. Nuclear 
translocation  was performed as described under  "Materials  and  Meth- 
ods." Nuclei were  isolated from cells (CHOP638  and CHOA-638) incu- 
bated for 90 min a t  37 "C in  the  presence of T - h G H  (approximately 
200,000 cpm) 2 excess (10 pg/ml) hGH and subjected to SDS-PAGE. 
Lane 1, I2'II-hGH. Lane 2, CH04-638 cell nuclei. Lane 3, CH04-638 cell 
nuclei  when  nuclear  uptake  was performed in  the presence of excess 
unlabeled hGH. Lane 4,  CHOA-638 cell nuclei. Lane 5, CHOA-638 cell 
nuclei  when  nuclear  uptake  was performed in  the presence of excess 
unlabeled hGH. Lane 6, "'I-hGH. 
hormone. Drugs affecting the  intermediate  filaments (demecol- 
cine and acrylamide) significantly increased the level of inter- 
nalized hormone but were without effect on  cell surface recep- 
tor, hormone degradation, or hormone nuclear uptake (Fig. 
8 0 .  The pharmacological activity of these  drugs  was evidenced 
by disruption of the  intermediate filament  network (as demon- 
strated by immunofluorescence for vimentin as previously de- 
scribed by Perrot-Applanat et al. (49); data not shown). Drug 
combinations (demecolcine, 2 p ~ ,  and cytochalasin B, 20 m) 
resulting  in  the  disruption of all three cytoskeletal networks 
were without effect on hormone nuclear uptake. 
DISCUSSION 
We have examined the  intracellular movement of GH and 
found that  the hormone is translocated to the nucleus in a 
receptor-dependent manner. This nuclear translocation was 
demonstrated both in  vivo at the  ultrastructural level and by 
scribed  under  "Materials  and Methods." Total added  radioactivity  was 
ence of 10 pg/ml unlabeled  hGH. B, hormone internalization  in cells 
150,000 cpm per  plate. Nonspecific uptake  was  estimated  in  the  pres- 
expressing  the GH receptor  (CH04-638, CHOA-638), the  GHBP (CHO- 
BP2),  and  the  parental ce l line (CHO). Cells  were  prepared as  described 
under  "Materials  and Methods." Total added  radioactivity  was 150,000 
cpm  per well/plate. Nonspecific uptake  was  estimated  in  the  presence of 
10 pg/ml unlabeled  hGH. ***, p < 0.001 when  compared to parental cell 
line. C ,  hormone  nuclear  uptake  in cells expressing  the GH receptor 
(CH04-638, CHOA-6381, the  GHBP (CHO-BPB), and  the  parental cell 
line (CHO). Cells were prepared as described under "Materials and 
Methods." Total added radioactivity was 150,000 cpm per well/plate. 
Nonspecific uptake  was  estimated  in  the  presence of 10 pg/ml unlabeled 
hGH. ***, p < 0.001 when  compared  to  parental cell line. 
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FIG. 7. A, effect of lysosomotropic agents on  cell surface  receptor,  hormone  internalization,  hormone  degradation,  and  hormone  nuclear  uptake 
(chloroquine, 10 mM, and ammonium  chloride, 50 m). Results are expressed as the percentage of control (untreated CH04-638) and represent the 
mean of triplicate  determinations  with S.D. indicated. Total  added  radioactivity was approximately 150,000 cpm. *, p < 0.05; **, p < 0.005, when 
compared to  control  values. B,  effect of bacitracin on  cell surface receptor,  hormone internalization, hormone degradation,  and hormone  nuclear 
Results are expressed as the percentage of control (untreated CH04-638) and  represent he mean of triplicate  determinations  with S.D. indicated. 
uptake in CH04-638 cells. All four parameters were measured as described under  “Materials  and Methods” aRer exposure to bacitracin at 5 mg/ml. 
Total added radioactivity was approximately 150,000 cpm. **, p < 0.005; ***, p < 0.001, when compared to control  values. 
use of receptor-transfected cells. The specificity of this  translo- 
cation  is  demonstrated by the  fact that: (a) concommitant in- 
jection of excess unlabeled  ligand  reduces  grain  density a t   the  
ultrastructural level to  background; ( b )  co-incubation of GH 
receptor-transfected cells with excess unlabeled  ligand  but not 
with  unrelated  ligands  prevents labeled  hormone uptake  to  the 
nuclear fraction; (c)  there are  differential  kinetics between in- 
ternalization  and  nuclear  translocation both at the  ultrastruc- 
tural level and  with  receptor-transfected cells; ( d )  there is satu- 
ration of nuclear translocation in vitro before saturation of 
internalization; ( e )  there is no significant specific nuclear  up- 
take  in  receptor-transfected cells incubated at 4 “C; ( f ,  there is 
no significant specific nuclear  uptake  in  the  untransfected pa- 
rental cell line  nor in a cell line  expressing a membrane bound 
but cytoplasmic domain  (and  internalization) deficient recep- 
tor. Thus one intracellular  destination of GH after  internaliza- 
tion is the nucleus. 
The  internalization  and  nuclear  translocation  pathway  uti- 
lized by GH is likely to  be shared by other polypeptide growth 
factors. Thus we describe here a receptor-mediated  endosomal 
pathway  for  the  nuclear  translocation of GH. This  is  further 
substantiated by the  fact  that lysosomotropic agents  increase 
nuclear  uptake of GH in the  GH  receptor cDNA-transfected cell 
lines. Moreover, in vivo the hormone appears rapidly at the 
plasma  membrane  and  in endosomal bodies before transloca- 
tion  to  the  nuclear  membrane  and finally the  nuclear  matrix. 
That the actual translocation is achieved by passage of the 
hormone  via  the  nuclear pore or by membranovesicular fusion 
(60)  or  both is possible. The  EM  analysis described here sug- 
gests  that before nuclear  translocation,  the hormone binds  rap- 
idly to  the  nuclear  membrane before slower translocation  to  the 
nuclear  matrix,  presumably  through  nuclear pores  since label 
was observed to be associated  with  these  structures in  vivo. It 
does appear, however, that at least  insulin (61), interleukin-la 
(36), EGF  (26,62),  and  prolactin  (21)  also  utilize  this endosomal 
route for nuclear  translocation of the hormone. Thus  inhibitors 
of lysosomal  hydrolytic activity  enhance  nuclear  accumulation 
of EGF  (27,621  and  IL-la  (36) as is the  case  here for GH. In  this 
study we observed a rapid  nuclear  translocation of hormone 
both in vivo at the  ultrastructural level and in  vitro. Translo- 
cation of GH  in this study occurred in a similar  time  frame  to 
that previously reported for insulin (22, 23, 63), gonadotropin 
releasing hormone (341, FGF (35), nerve growth factor (28), 
atrial  natriuretic  peptide (331, and  gonadotropin-releasing fac- 
tor (44). However, the  time  taken for nuclear  translocation of 
other polypeptide ligands  varies enormously. The  nuclear 
translocation of EGF  continues for 24-48  h after  addition of 
hormone  (28, 62)  and  maximal IL-2 stimulated  nuclear  trans- 
location of prolactin is attained between 18 and 24 h (21). 
Similarly  somatostatin-28  requires 18 h to  enter  the  nuclear 
compartment (31). 
Nuclear  translocation of hormone was observed in  GH recep- 
tor  but  not  GHBP-transfected cells. Thus  nuclear  translocation 
of GH  is receptor dependent.  This conclusion is concordant with 
receptor-dependent  translocation to  the  nucleus of epidermal 
growth factor and  nerve  growth factor  (28). However, whether 
the receptor is  required only for internalization of GH  and not 
intracellular movement of the hormone could not be deter- 
mined. I t  is possible that once internalized  the hormone-recep- 
tor complex could dissociate and  the hormone translocate by a 
receptor-independent pathway, perhaps complexed to  the 
GHBP. It   has previously been  demonstrated that such a situ- 
ation exists for insulin (64) and prolactin (65), whereby the 
hormone-receptor complex is transported  to the nuclear periph- 
ery  but only the  ligand  is  subject to nuclear  translocation.  Fur- 
thermore,  mutation of the  nuclear localization  sequences in  the 
IL-1  receptor do not affect the  functional  response  to hormone 
(66)  and IL-1 is still  nuclear localized with most of the cyto- 
plasmic  portion of the receptor deleted (67). Some polypeptide 
ligands (platelet-derived growth factor, FGF, and IL-1) also 
nuclear  translocate  due  to  the presence of a nuclear localization 
signal in  their  primary sequence (68-70). 
The  functional significance of a nuclear  GH receptor (9) and 
nuclear  translocation of GH has not  yet  been  demonstrated. 
Functional  activity of other  nuclear  translocated polypeptide 
ligands has been clearly demonstrated ( e g .  Refs. 68  and 71). 
For example, acidic FGF  lacking a putative  nuclear localization 
sequence  fails  to  induce DNA synthesis and cell proliferation at 
concentrations sufficient to  induce  intracellular receptor-medi- 
ated  tyrosine phosphorylation and c-fos expression. However, 
attachment of the  nuclear localization  sequence  from yeast his- 
tone  2B to  the  amino  terminus of acidic FGF  results  in  resto- 
ration of mitogenic activity (68). A similar phenomenon was 
observed  for  prolactin in which enhancement of IL-2 induced 
proliferation was observed when a  chimeric  prolactin molecule 
containing  the SV40 nuclear localization sequence was used 
(71). No canonical nuclear localization  sequences (72)  are  pres- 
ent  in  GH  (73)  and  thus it is likely that GH arrives in the 
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FIG. 8. A, effect of microtubular disrupting agents on cell surface 
receptor,  hormone internalization, hormone degradation, and hormone 
nuclear uptake in CH04-638 cells. All four parameters were measured 
as described under “Materials and Methods” after exposure to the re- 
spective drug (colchicine, vincristine, and vinblastine at 10 p). Results 
are expressed as the percentage of control (untreated CH04-638) and 
represent the mean of triplicate determinations with S.D. indicated. 
Total added radioactivity was approximately 150,000 cpm. *, p < 0.005. 
B,  effect of microfilament disrupting agents on cell surface receptor, 
hormone internalization, hormone degradation, and hormone nuclear 
uptake in  CH04-638 cells. All four parameters were measured as de- 
scribed under “Materials and Methods” after exposure  to the respective 
drug (cytochalasin B at 20 p and phalloidin at 10 p). Results are 
expressed as  the percentage of control (untreated CHO4-638) and rep- 
resent  the mean of triplicate determinations with S.D. indicated. Total 
added radioactivity was approximately 150,000 cpm. C, effect of inter- 
mediate filament disrupting agents on cell surface receptor,  hormone 
internalization, hormone degradation, and hormone nuclear uptake  in 
CH04-638 cells. All four parameters were measured as described under 
“Materials and Methods” after exposure  to the respective drug (deme- 
colcine at 5 p and acrylamide at 5 mM). Results are expressed as the 
percentage of control (untreated CH04-638) and represent the mean of 
triplicate determinations with S.D. indicated. Total added radioactivity 
was approximately 150,000 cpm. *, p < 0.05. 
nucleus in conjunction with an associated molecule,  most  prob- 
ably the receptor. Indeed, in preliminary experiments we have 
ent nuclear translocation.’ Whether the nuclear hormone-re- 
ceptor complex is involved in transcriptional events or  cell  cycle 
regulation or both remains to  be determined. It is possible that 
immediate and common events in signal transduction such as 
early response  gene stimulation are dependent on protein phos- 
phorylation, whereas ligand-dependent gene transcription and 
cell  proliferation  may require nuclear translocation of hormone 
and/or  receptor. We have so far obtained no evidence that GH or 
a GH-GH receptor-BP complex is able to bind to DNA (Spi 2.1 
promotor) either directly or indire~tly.~ We are presently inves- 
tigating whether chimeric GH molecules containing the SV40 
nuclear localization  sequence  display enhanced biological 
activity. 
We did not observe any effect of the disruption of the cy- 
toskeletal system on the nuclear translocation of GH.  These 
results suggest that  the cell has access to a nuclear transloca- 
tion  mechanism for  GH that does  not operate through any of 
the  three main  cytoskeletal  networks. This is interesting con- 
sidering the well  known interaction between the cytoskeleton 
and endosomes ( e g .  Ref. 74). However, early endosomal  func- 
tion does not require an intact microtubular network (75). 
Since the hormone arrives at the nuclear membrane and the 
lysosomal compartment simultaneously,  both destinations may 
be mediated by the microtubular independent endosomal path- 
way. Such  cytoskeletal  system independent nuclear transloca- 
tion of proteins has also  been reported for the adenovirus E1A 
protein (591, the 72- (59) and 90-kDa (76) heat shock proteins, 
and the progesterone  receptor (49). Moreover, the GH receptor4 
is not incorporated into vinblastine-induced paracrystals (76) 
indicative that  the receptor is not  associated at least with the 
microtubular network. Nevertheless, we cannot exclude the 
possibility that the GH receptor  may  associate  with some  cy- 
toskeletal component, since the receptor is ubiquinated (77) 
and ubiquitin is  a component of the microtubular network (78). 
Indeed, the EGF  receptor is  an actin-binding protein (79) and is 
known to associate with the cytoskeletal network. Further- 
more, transport of the GH receptor  from the Golgi apparatus to 
the plasma membrane has been reported to  be dependent on 
both the microfilamentous and microtubular network (47). 
In conclusion, we have  shown a receptor-dependent nuclear 
translocation of GH.  At present the functional significance of 
such an intracellular fate for GH is not  known. That nuclear 
targeting of other polypeptide ligands confers a complete  bio- 
logical  response (at least  in terms of mitogenesis) lends cre- 
dence to  functionality of intranuclear GH. Whether the in- 
tranuclear ligand is only required for  cell  cycle vents or ligand- 
dependent transcriptional activation needs to be determined. It 
is possible that  the liganded  receptor (or the activated unligand- 
ed receptor) participates in  a transcription complex although 
we have no  evidence to support this contention. Transcription 
factor p91(80)  has previously  been  shown to associate  directly 
with the EGF  receptor (81). Such direct receptor-transcription 
factor associations would  provide the required transcriptional 
specificity  necessary  from shared kinase activation. 
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